Daily non-political popular news in brief.

People with genetic predictors of colorectal cancer are not getting screened

02-22-2007 · EurekAlert!

Even when diagnosed with a condition that is a strong genetic predictor of colorectal cancer, many patients do not seek out genetic counseling or cancer screening. According to a recent study in the American Journal of Gastroenterology, counseling and screening rates could be improved if physicians provided stronger encouragement and more complete information about the benefits of screening to their patients.

Keywords: people, genetic, predictors, colorectal, cancer, getting, screened, predictor

« Previous | Next »

Similar news on "People with genetic predictors of colorectal cancer are not getting screened":

Recent studies confirm significant underuse of colorectal cancer screening
12-17-2007 · EurekAlert!
Two recently released studies confirm an alarming reality, that a majority of Americans who should be getting screened for colorectal cancer are not. According to a study in the journal Cancer, among an assessment of Medicare beneficiaries between 1998 and 2004, only 25.4 percent of people were screened, despite Medicare coverage for colorectal cancer screening. Figures released by the Agency for Healthcare Research and Quality show that only half of Americans age 50 and over have had a screening colonoscopy.
Similar news · Read more »
Virtual colonoscopy effective in preventing colorectal cancer
10-17-2006 · EurekAlert!
Three-dimensional computed tomography colonography, also known as virtual colonoscopy, is an accurate screening method for colorectal cancer, according to a study published in the November issue of the journal Radiology. In addition, when covered by third-party payers, virtual colonoscopy may entice more people to be screened.
Similar news · Read more »
Genes and biomarkers that allow doctors to choose the right therapy for the right patient
04-17-2007 · EurekAlert!
Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers. Now, researchers have the tools and the knowledge to help predict how individuals will respond to cancer therapies, enabling them to create more effective therapies for individual cancers -- personalized medicine.
Similar news · Read more »
Exploring better ways to determine when to change the course of treatment
06-03-2007 · EurekAlert!
Counting circulating tumor cells before and after the start of treatment for patients with metastatic colorectal cancer could help doctors determine when or if a change in treatment should be made. The results of a large, multicenter study laying the groundwork for such decisions will be presented at the annual meeting of the American Society of Clinical Oncology. The study showed the number of circulating tumor cells is a significant predictor of survival and cancer progression.
Similar news · Read more »
It takes a community to address cancer disparities among underserved minority populations
11-30-2007 · EurekAlert!
Cancer affects whole communities of people with similar genetic heritage and cultural behaviors, yet medical researchers often have trouble uncovering data on minority populations and promoting changes that could improve health. That is why many researchers have begun to collaborate directly with community groups. Such associations can improve the quality of data collection; provide needed insight into social factors involving help; and lead to sustained health improvements among disadvantaged populations.
Similar news · Read more »
Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
09-10-2007 · EurekAlert!
A genetic variant present in nearly half of Americans of European ancestry is linked to greater effectiveness of the smoking cessation medication bupropion (Zyban), according to research by scientists supported by the National Institute on Drug Abuse and the National Cancer Institute, part of the National Institutes of Health. People with this variant were less likely than those without it to have resumed smoking six months after treatment with bupropion.
Similar news · Read more »
Genetic differences point to ethnic and racial disparities in colorectal cancer risk
11-28-2007 · EurekAlert!
Risk of developing colorectal cancer is known to differ across ethnic and racial groups, and now an analysis of 26 studies, involving over 25,000 participants shows that some of these disparities might be explained by distinct patterns of genetic inheritance. A team of researchers, led by investigators at the University of Pittsburgh, present their findings today in Atlanta at the AACR conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, being held Nov. 27-30.
Similar news · Read more »
DNA (driver of nicotine addiction)
01-29-2008 · EurekAlert!
One in eight US adults smokes a pack of cigarettes each day. Nicotine is the addicting substance in cigarettes. Most of the risk for habitual heavy smoking is genetic. DNA samples from 14,000 people were studied to determine what DNA variants predict risk for habitual smoking. The most important genetic predictors of habitual smoking were variants in genes producing brain proteins to which nicotine binds in the process of generating its addicting effects.
Similar news · Read more »
Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients
10-15-2007 · EurekAlert!
Mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when comparing cases and controls. Patients with IBD are at significantly higher than average risk for colorectal cancer and should be screened more frequently, but another study revealed many don't get recommended tests.
Similar news · Read more »
Studies examine colorectal cancer screening rates
11-13-2006 · EurekAlert!
The rate of colorectal cancer screening appears to be increasing among Veterans Affairs patients, although use of colonoscopy is less common than other screening procedures, according to a report in the Nov. 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. A second report in the same journal shows that younger veterans with other illnesses and reduced life expectancies may not necessarily benefit from such screening and may even be harmed, but continue to be screened at high rates.
Similar news · Read more »